199 related articles for article (PubMed ID: 3755630)
1. Pharmacology of aminoglutethimide: structure/activity relationships and receptor interactions.
Nicholls PJ; Daly MJ; Smith HJ
Breast Cancer Res Treat; 1986; 7 Suppl():S55-67. PubMed ID: 3755630
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biochemical evaluation of analogues of aminoglutethimide based on phenylpyrrolidine-2,5-dione.
Daly MJ; Jones GW; Nicholls PJ; Smith HJ; Rowlands MG; Bunnett MA
J Med Chem; 1986 Apr; 29(4):520-3. PubMed ID: 3754286
[TBL] [Abstract][Full Text] [Related]
3. Analogues of aminoglutethimide based on 1-phenyl-3-azabicyclo[3.1.0]hexane-2,4-dione: selective inhibition of aromatase activity.
Rowlands MG; Bunnett MA; Foster AB; Jarman M; Stanek J; Schweizer E
J Med Chem; 1988 May; 31(5):971-6. PubMed ID: 3361583
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and aromatase inhibiting activity of aminoglutethimide analogs.
Aboul-Enein HY
Drug Des Deliv; 1988 Feb; 2(3):221-6. PubMed ID: 3255316
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline.
Kellis JT; Vickery LE
Endocrinology; 1984 Jun; 114(6):2128-37. PubMed ID: 6723577
[TBL] [Abstract][Full Text] [Related]
6. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
Murphy MJ
Oncologist; 1998; 3(2):129-130. PubMed ID: 10388095
[TBL] [Abstract][Full Text] [Related]
7. Analogues of aminoglutethimide: selective inhibition of aromatase.
Foster AB; Jarman M; Leung CS; Rowlands MG; Taylor GN; Plevey RG; Sampson P
J Med Chem; 1985 Feb; 28(2):200-4. PubMed ID: 3968684
[TBL] [Abstract][Full Text] [Related]
8. Basic studies on aminoglutethimide.
Salhanick HA
Cancer Res; 1982 Aug; 42(8 Suppl):3315s-3321s. PubMed ID: 7083193
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of aromatase as treatment of breast carcinoma in postmenopausal women.
Santen RJ; Boucher AE; Santner SJ; Henderson IC; Harvey H; Lipton A
J Lab Clin Med; 1987 Mar; 109(3):278-89. PubMed ID: 3546561
[TBL] [Abstract][Full Text] [Related]
10. Molecular modelling study of pyrrolidine-2,5-dione based aromatase inhibitors and other known inhibitors.
Ahmed S
Drug Des Discov; 1996 Mar; 14(1):77-89. PubMed ID: 8854046
[TBL] [Abstract][Full Text] [Related]
11. Overview of recent development of aromatase inhibitors.
Brodie AM
Cancer Res; 1982 Aug; 42(8 Suppl):3312s-3314s. PubMed ID: 7083192
[TBL] [Abstract][Full Text] [Related]
12. Aromatase inhibitors--mechanisms for non-steroidal inhibitors.
Vanden Bossche HV; Moereels H; Koymans LM
Breast Cancer Res Treat; 1994; 30(1):43-55. PubMed ID: 7949204
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biochemical evaluation of novel inhibitors of aromatase (AR) using an enhanced representation of the active site of AR derived from the consideration of the reaction mechanism.
Ahmed S; Amanuel Y
Biochem Biophys Res Commun; 2000 Jan; 267(1):356-61. PubMed ID: 10623624
[TBL] [Abstract][Full Text] [Related]
14. Analogues of aminoglutethimide: selective inhibition of cholesterol side-chain cleavage.
Foster AB; Jarman M; Leung CS; Rowlands MG; Taylor GN
J Med Chem; 1983 Jan; 26(1):50-4. PubMed ID: 6827528
[TBL] [Abstract][Full Text] [Related]
15. The use of the substrate-heme complex approach in the design, synthesis, biochemical evaluation, and rationalization of the inhibitory activity of a range of azole compounds against cholesterol side chain cleavage enzyme.
Ahmed S
Biochem Biophys Res Commun; 2000 Aug; 275(1):75-6. PubMed ID: 10944444
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro pharmacological studies of aminoglutethimide as an aromatase inhibitor.
Santen RJ; Santner SJ; Tilsen-Mallett N; Rosen HR; Samojlik E; Veldhuis JD
Cancer Res; 1982 Aug; 42(8 Suppl):3353s-3359s. PubMed ID: 7083200
[TBL] [Abstract][Full Text] [Related]
17. Aromatase inhibitors: new endocrine treatment of breast cancer.
Brueggemeier RW
Semin Reprod Med; 2004 Feb; 22(1):31-43. PubMed ID: 15083379
[TBL] [Abstract][Full Text] [Related]
18. Biochemistry and pharmacology of 7alpha-substituted androstenediones as aromatase inhibitors.
Brueggemeier RW; O'Reilly JM; Lovely CJ; Ward PJ; Quinn AL; Baker D; Darby MV; Gu XJ; Gilbert NE
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):247-54. PubMed ID: 9365197
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies of aromatase inhibitors in relation to the significance of estrogen synthesis in human mammary tumors.
Abul-Hajj YJ
Cancer Res; 1982 Aug; 42(8 Suppl):3373s-3377s. PubMed ID: 6211227
[TBL] [Abstract][Full Text] [Related]
20. Molecular modelling study of the binding of inhibitors of aromatase to the cytochrome P-450 heme.
Ahmed S; Davis PJ; Owen CP
Drug Des Discov; 1996 Oct; 14(2):91-102. PubMed ID: 9010616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
